eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
5.60
-0.42 (-6.98%)
Jul 20, 2026, 4:00 PM EDT - Market closed
eXoZymes Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
32
Market Cap
47.48M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 70.07K | 41.47K | 145.01% |
| Dec 31, 2022 | 28.60K | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Radiopharm Theranostics | 10.86M |
| Immutep | 5.28M |
| BeyondSpring | 1.88M |
| Seres Therapeutics | 1.15M |
| Mereo BioPharma Group | 500.00K |
| aTyr Pharma | 190.00K |
| INmune Bio | 50.00K |
| Impact BioMedical | 39.00K |
EXOZ News
- 5 days ago - eXoZymes Inc trading resumes - TheFly
- 5 days ago - eXoZymes Inc trading halted, volatility trading pause - TheFly
- 26 days ago - eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery - Accesswire
- 4 weeks ago - eXoZymes Inc. Announces Closing of $6 Million Public Offering - Accesswire
- 6 weeks ago - eXoZymes prices 592,270 shares at $18.00 in public offering - TheFly
- 6 weeks ago - eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants - Accesswire
- 2 months ago - eXoZymes Quarterly report: Q1 2026 - Filings
- 2 months ago - eXoZymes announces graduation from Shell GameChanger Accelerator - TheFly